Rare Disease CROs in Sweden

Swedish CRO with a 12-bed first-in-human research unit at Uppsala University Hospital, specializing in Phase I and Phase II trials with approximately five FIH studies annually.

Stockholm-based Nordic CRO providing clinical trial management, biostatistics, and regulatory support for Phase I-IV studies across Scandinavian countries with EMA and FDA regulatory experience.

Mid-size global CRO with nearly 700 professionals across 50 countries, specializing in oncology, rare disease, and complex clinical programs with particular strength in dermatology and CNS.